4
Changes in Ownership
Kairos Pharma, LTD. Filed Acc 0001493152-24-047695
VP of Research and Development bought 200 shares at $1.59 ($318)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murali Ramachandran VP of Research and Development | 2024-11-25 | Purchase | +200 | $1.59 | $318 | 133,057 | D |
| Open-market purchases · 200 sh · avg $1.59 · $318 | |||||||
Loading xslF345X05/ownership.xml…